← FDA Drug Approvals (Drugs@FDA)

APIXABAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2023-02-27

Drug application

FDA Application #

ANDA210185

Application type

Abbreviated New Drug Application (Generic)

Brand name

APIXABAN

Generic name

Apixaban

Active ingredients

APIXABAN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ZYDUS PHARMS

First approval

2023-02-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown